These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2492085)

  • 1. Tissue plasminogen activator.
    N Engl J Med; 1989 Feb; 320(5):317-8. PubMed ID: 2492085
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue plasminogen activator for coronary thrombosis.
    DiPalma JR
    Am Fam Physician; 1988 Mar; 37(3):291-5. PubMed ID: 3126630
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue plasminogen activator (t-PA). Will it fulfill its promise?
    Sherry S
    N Engl J Med; 1985 Oct; 313(16):1014-7. PubMed ID: 3930959
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue-type plasminogen activator for acute coronary thrombosis. The Medical Letter.
    Conn Med; 1988 Feb; 52(2):105-6. PubMed ID: 3126023
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic thrombolysis: tissue-type plasminogen activator.
    Sobel BE
    Circulation; 1987 Aug; 76(2 Pt 2):II39-43. PubMed ID: 3111746
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue plasminogen activator.
    de Bono DP
    Br J Hosp Med; 1986 Aug; 36(2):87. PubMed ID: 3091129
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary thrombolysis with tissue-type plasminogen activator: an overview.
    Van de Werf F; Collen D
    Eur Heart J; 1985 Nov; 6(11):902-4. PubMed ID: 3935445
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue-type plasminogen activator for acute coronary thrombosis.
    Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
    [No Abstract]   [Full Text] [Related]  

  • 9. Validity of the GUSTO trial's main conclusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.
    Eisenberg C
    Pharmacotherapy; 1997; 17(4):850-2. PubMed ID: 9250573
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute reduction of lipoprotein(a) by tissue-type plasminogen activator.
    Di Lorenzo M; Salvini P; Levi Della Vida M; Maddaloni E
    Circulation; 1993 Mar; 87(3):1052-3. PubMed ID: 8443887
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis during acute myocardial infarction.
    Lew AS; Ganz W
    Acute Care; 1985; 11(1):3-39. PubMed ID: 2940795
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary thrombolysis with tissue-type plasminogen activator.
    Bergmann SR; Ludbrook PA; Sobel BE
    Cardiol Clin; 1987 Feb; 5(1):101-11. PubMed ID: 3103916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reocclusion after treatment with actilyse].
    Raynaud P; Desveaux B
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():25-32. PubMed ID: 3142416
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary thrombolysis.
    Thomas P; Sheridan DJ
    Q J Med; 1988 Sep; 68(257):657-63. PubMed ID: 2978484
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and preclinical studies on improved thrombolytic therapy. Research contributions during the period 1986-1990.
    Collen D
    Bull Mem Acad R Med Belg; 1992; 147(11-12):441-9. PubMed ID: 1341569
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of coronary thrombolysis.
    Tiefenbrunn AI; Robison AK; Sobel BE
    Cardiol Clin; 1987 Feb; 5(1):125-8. PubMed ID: 3103917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Canadian Consensus Conference on Coronary Thrombolysis--current aspects].
    Cairns J; Armstrong P; Belenkie I; Hirsh J; Johnstone D; Knudtson M; Lemieux M; Massel D; Naylor D; Roy L
    Can J Cardiol; 1995; 11(7):581-6. PubMed ID: 7656193
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of the thrombolysis and angioplasty in acute myocardial infarction (TAMI) trials.
    Topol EJ
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():45-9. PubMed ID: 2973302
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient.
    Wakeham MK; Van Bergen AH; Torero LE; Akhter J
    Pediatr Crit Care Med; 2005 Jan; 6(1):76-8. PubMed ID: 15636664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.